Bayer Cropscience Other Announcement
Bayer CropScience Limited has announced the closure of its trading window for designated persons, effective from October 1, 2026, until November 16, 2026.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
25 announcements with these filters
Bayer CropScience Limited has announced the closure of its trading window for designated persons, effective from October 1, 2026, until November 16, 2026.
Bayer CropScience seeks member approval via postal ballot to appoint Mr. Ravi Kirpalani as Independent Director for five years. Voting window: September 14 to October 13, 2026.
Bayer CropScience Ltd has been assigned an ESG rating of 'Crisil ESG 66' and 'Crisil Core ESG 70' by Crisil ESG Ratings and Analytics Limited.
Bayer CropScience held its 68th Annual General Meeting on August 19, 2026. Shareholders approved all resolutions, including final dividend declaration and material related party transactions.
Bayer CropScience reported Q1 FY2026-27 revenue of ₹1,835 Crore and Profit Before Tax of ₹402.1 Crore. Management highlighted resilient performance amid challenging weather and market conditions.
Bayer CropScience Ltd announced the appointment of Mr. Ravi Moti Kirpalani as an Additional Independent Director and Chairman, succeeding Mr. Pankaj Ramanbhai Patel.
Bayer Cropscience Ltd reported revenue from operations of ₹1,835 Cr (-4.2% YoY) and net profit of ₹321.6 Cr (+15.4% YoY) for Q1 FY27.
Bayer AG acquired 5,35,030 equity shares of Bayer CropScience Ltd via an inter-se transfer. The transaction occurred between promoters on July 8, 2026.
Bayer CropScience Ltd filed its Business Responsibility and Sustainability Report for the financial year ended March 31, 2026. This report is integrated into the company's Annual Report.
Bayer CropScience Ltd issued a notice for its 68th Annual General Meeting scheduled for August 19, 2026. The agenda includes dividend approval and related party transactions.
Bayer CropScience Limited has submitted its 68th Annual Report for the Financial Year 2025-26. The document includes the Notice for the upcoming Annual General Meeting.
Bayer CropScience Ltd has filed its quarterly shareholding pattern disclosure for the period ending June 30, 2026.
Bayer CropScience scheduled a board meeting for August 05, 2026. The directors will consider unaudited financial results for the quarter ended June 30, 2026.
Bayer CropScience received a Rs. 2.2 Crore GST penalty order regarding outward supply and input tax credit issues. The company intends to appeal this regulatory order.
Bayer AG acquired a 11.91% stake in Bayer CropScience Ltd via an inter-se transfer for Rs 2,207.13 Crore. Its total holding increased to 20.34%.
Bayer AG acquired a 11.91% stake in Bayer CropScience for Rs. 2,207.1 Crore. This inter-se transfer via block deal increases its total holding to 20.34%.
Bayer AG, a promoter, acquired 53.54 lakh shares from Bayer CropScience AG through an inter‑se block deal. The transaction raises its voting stake to 20.34%.
Bayer AG acquired a 11.91% stake in Bayer CropScience via an inter-se promoter transfer. This transaction increases its holding from 8.43% to 20.34%.
Bayer CropScience Ltd will hold its 68th AGM on Aug 19, 2026, to approve a Rs.60/share final dividend. Payment is expected after Sept 3, 2026.
Bayer AG will buy up to 5.35 million Bayer CropScience shares for ₹4,434 each (~₹2,374 Cr). Deal uses a block‑deal and is exempt from an open offer.
Bayer CropScience Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms overall regulatory compliance with no material deviations.
Bayer CropScience reported ₹5,675.0 Crore annual revenue, up from the previous year. The Board recommended a ₹60 per share final dividend, reflecting resilient business performance.
Bayer Cropscience Ltd reported revenue from operations of ₹1,101 Cr (+5.2% YoY) and net profit of ₹162.1 Cr (+13.1% YoY) for Q4 FY26.
Bayer CropScience reported annual audited net profit of ₹6,892 million for FY2026. The board recommended a final dividend of ₹60 per equity share.
Bayer CropScience scheduled a board meeting for May 26, 2026. Directors will consider audited annual financial results and final dividend recommendations.